Cochlear implant maker Med-El USA said today it won FDA approval for its Rondo 2 cochlear implant audio processor with an expected launch of the device this fall.
The Durham, N.C.-based ocmpany said the newly cleared Rondo 2 audio processor features wireless charging capabilities that allow the device to fully recharge in four hours after being placed onto a charging pad, and can provide 18 hours of battery life.
The system is designed to be worn off the ear and can connect to cell phones, televisions, Bluetooth neckloops and hearing induction loops, Med-EL said, and can be discreetly hidden under hair.
“Rondo 2 is the easiest to use CI audio processor ever made. And because MED-EL engineers every internal cochlear implant to be future-ready, all of our recipients will be able to enjoy the latest industry-leading audio processing technology,” Med-El NA prez & CEO Raymond Gamble said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.